1. Home
  2. ELVA vs PBYI Comparison

ELVA vs PBYI Comparison

Compare ELVA & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Electrovaya Inc.

ELVA

Electrovaya Inc.

HOLD

Current Price

$9.52

Market Cap

466.7M

Sector

N/A

ML Signal

HOLD

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

HOLD

Current Price

$8.54

Market Cap

428.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELVA
PBYI
Founded
1996
2010
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
466.7M
428.1M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
ELVA
PBYI
Price
$9.52
$8.54
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$14.00
N/A
AVG Volume (30 Days)
332.1K
376.3K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$27,685,000.00
Revenue This Year
$34.68
N/A
Revenue Next Year
$51.48
N/A
P/E Ratio
$78.51
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.66
$3.03
52 Week High
$12.78
$8.66

Technical Indicators

Market Signals
Indicator
ELVA
PBYI
Relative Strength Index (RSI) 48.72 66.22
Support Level $8.96 $6.50
Resistance Level $11.17 N/A
Average True Range (ATR) 0.89 0.38
MACD 0.06 0.02
Stochastic Oscillator 38.97 88.88

Price Performance

Historical Comparison
ELVA
PBYI

About ELVA Electrovaya Inc.

Electrovaya Inc is a technology-focused lithium-ion battery company engaged in designing, developing and manufacturing battery cells, modules and systems based on its proprietary Infinity Battery Technology, which provides high safety performance, long cycle life and durability. The Company supplies low-voltage and high-voltage battery systems for industrial and transportation markets, including material-handling equipment, robotic vehicles, electric buses and trucks, and energy-storage installations, and its products are suitable for mission-critical applications. it maintains an expanding intellectual-property portfolio, develops next-generation solid-state and hybrid solid-state battery technologies, and sells its products through OEM relationships, dealer networks and direct sales.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: